A Brief Review on the Development of Novel Potentially Active Azetidin-2-ones against Cancer

(E-pub Ahead of Print)

Author(s): Ligia Pinto, Thatyana Vasconcelos*, Claudia Gomes, Marcus De Souza.

Journal Name: Current Organic Chemistry

Become EABM
Become Reviewer


Azetidin-2-ones (β-lactams) and its derivatives are an important group of heterocyclic compounds that exhibit a wide range of pharmacological properties such as antibacterial, anticancer, anti-diabetic, anti-inflammatory and anticonvulsant. Efforts have been made over the years to develop novel congeners with superior biological activities and minimal potential for undesirable side effects. The present review aims to highlight some recent discoveries (2013-2019) on the development of novel azetidin-2-one-based compounds as potential anticancer agents.

Keywords: Azetidin-2-ones, β-lactams, Biological activity, Cancer, Drugs, Heterocycles

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1385272824666200303115444
Price: $95